Le Lézard
Classified in: Health
Subjects: MAV, CMG

/R E P E A T -- Media Advisory - City of Toronto to host technical briefing on new mental health and substance use strategy/


TORONTO, Nov. 19, 2023 /CNW/ - The City of Toronto will hold a technical briefing on Monday, November 20, to introduce media to "Our Health, Our City: A Mental Health, Substance Use, Harm Reduction and Treatment Strategy for Toronto." Toronto's Medical Officer of Health, Dr. Eileen de Villa, Uppala Chandrasekera, Director, Public Health, and Dr. Shovita Padhi, Associate Medical Officer of Health will provide an overview of the strategy to media.

Following the technical media briefing, an in-person launch event will be held at Toronto City Hall that will be attended by Deputy Mayor Ausma Malik (Spadina-Fort York) and Chair of the Board of Health, Councillor Chris Moise (Toronto Centre).  

Date:

Monday, November 20

Time:

8:30 a.m. (Technical briefing ? online only). Registration details below.
9:15 a.m. (Media availability).City Hall, 100 Queen St. W., A-Street Reception

Media can register for the technical media briefing here:
https://toronto.webex.com/weblink/register/rabf59d52af08d0cf1185ebbbe8be9e7b 

Note: Media will be provided access to the presentation deck and strategy document 30 minutes prior to the technical briefing.

Toronto is home to more than three million people whose diversity and experiences make this great city Canada's leading economic engine and one of the world's most diverse and livable cities. As the fourth largest city in North America, Toronto is a global leader in technology, finance, film, music, culture, innovation and climate action, and consistently places at the top of international rankings due to investments championed by its government, residents and businesses. For more information visit www.toronto.ca or follow us on Twitter at www.twitter.com/CityofToronto, on Instagram at www.instagram.com/cityofto or on Facebook at www.facebook.com/cityofto

SOURCE Toronto Public Health


These press releases may also interest you

at 18:27
Andreozzi + Foote is deeply troubled by revelations of sexual abuse perpetrated by Ramon Garcia against patients at Carbon Health Urgent Care in Jenkintown and possibly other locations. Our client, Jane Doe, bravely stepped forward to share her...

at 18:14
SARC (Sarcoma Alliance for Research Through Collaboration) is proud to announce the launch of the Sarcoma Centers Registry https://sarctrials.org/sarcoma-centers/, a comprehensive, global resource facilitating...

at 18:08
Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced with great respect and sorrow the unexpected passing last night of...

at 18:02
It takes a unique, special kind of dedication to become a nurse. For the nurses in First Nations and Inuit communities, it takes strength, resiliency, expertise, and most importantly, heart. It takes an understanding of the complex environment of...

at 17:44
On Tuesday, May 7, 2024, The Center for Discovery® (TCFD, The Center) honored Edward C. Sweeney, TCFD Board Chair, at the 24th annual Evening of Discovery Gala. The Gala was hosted by Mo Rocca, CBS Sunday Morning Correspondent, Humorist, and Creator...

at 17:30
PT217 is Phanes' first-in-class bispecific antibody targeting DLL3 and CD47; atezolizumab (TECENTRIQ®) is Roche's anti-PD-L1 monoclonal antibodyThe clinical supply agreement will focus on evaluating PT217 in combination with atezolizumab for the...



News published on and distributed by: